Antibodies Against Egg- and Cell-Grown Influenza A(H3N2) Viruses in Adults Hospitalized During the 2017-2018 Influenza Season.
Adult
Animals
Antibodies, Viral
/ immunology
Antigens, Viral
/ immunology
Cell Line
Dogs
Female
Hemagglutination Inhibition Tests
/ methods
Hong Kong
Humans
Influenza A Virus, H3N2 Subtype
/ immunology
Influenza Vaccines
/ immunology
Influenza, Human
/ immunology
Madin Darby Canine Kidney Cells
Male
Middle Aged
Seasons
Young Adult
Influenza A
antibodies
egg adaptation
vaccine effectiveness
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
24 05 2019
24 05 2019
Historique:
received:
11
10
2018
accepted:
29
01
2019
pubmed:
6
2
2019
medline:
25
2
2020
entrez:
6
2
2019
Statut:
ppublish
Résumé
Influenza vaccine effectiveness was low in 2017-2018, yet circulating influenza A(H3N2) viruses were antigenically similar to cell-grown vaccine strains. Notably, most influenza vaccines are egg propagated. Serum specimens were collected shortly after illness onset from 15 influenza A(H3N2) virus-infected cases and 15 uninfected hospitalized adults. Geometric mean titers against egg- and cell-grown influenza A/Hong Kong/4801/2014(H3N2) virus vaccine strains and representative circulating viruses (including A/Washington/16/2017) were determined by a microneutralization (MN) assay. Independent effects of strain-specific titers on susceptibility were estimated by logistic regression. MN titers against egg-grown influenza A/Hong Kong virus were significantly higher among vaccinated individuals (173 vs 41; P = 0.01). In unadjusted models, a 2-fold increase in titers against egg-grown influenza A/Hong Kong virus was not significantly protective (29% reduction; P = .09), but a similar increase in the cell-grown influenza A/Washington virus antibody titer (3C.2a2) was protective (60% reduction; P = .02). Higher egg-grown influenza A/Hong Kong virus titers were not significantly associated with infection, when adjusted for antibody titers against influenza A/Washington virus (15% reduction; P = .61). A 54% reduction in the odds of infection was observed with a 2-fold increase in titer against influenza A/Washington virus (P = not significant), adjusted for the titer against egg-grown influenza A/Hong Kong virus titer. Individuals vaccinated in 2017-2018 had high antibody titers against the egg-adapted vaccine strain and lower titers against circulating viruses. Titers against circulating but not egg-adapted strains were correlated with protection.
Sections du résumé
BACKGROUND
Influenza vaccine effectiveness was low in 2017-2018, yet circulating influenza A(H3N2) viruses were antigenically similar to cell-grown vaccine strains. Notably, most influenza vaccines are egg propagated.
METHODS
Serum specimens were collected shortly after illness onset from 15 influenza A(H3N2) virus-infected cases and 15 uninfected hospitalized adults. Geometric mean titers against egg- and cell-grown influenza A/Hong Kong/4801/2014(H3N2) virus vaccine strains and representative circulating viruses (including A/Washington/16/2017) were determined by a microneutralization (MN) assay. Independent effects of strain-specific titers on susceptibility were estimated by logistic regression.
RESULTS
MN titers against egg-grown influenza A/Hong Kong virus were significantly higher among vaccinated individuals (173 vs 41; P = 0.01). In unadjusted models, a 2-fold increase in titers against egg-grown influenza A/Hong Kong virus was not significantly protective (29% reduction; P = .09), but a similar increase in the cell-grown influenza A/Washington virus antibody titer (3C.2a2) was protective (60% reduction; P = .02). Higher egg-grown influenza A/Hong Kong virus titers were not significantly associated with infection, when adjusted for antibody titers against influenza A/Washington virus (15% reduction; P = .61). A 54% reduction in the odds of infection was observed with a 2-fold increase in titer against influenza A/Washington virus (P = not significant), adjusted for the titer against egg-grown influenza A/Hong Kong virus titer.
CONCLUSION
Individuals vaccinated in 2017-2018 had high antibody titers against the egg-adapted vaccine strain and lower titers against circulating viruses. Titers against circulating but not egg-adapted strains were correlated with protection.
Identifiants
pubmed: 30721982
pii: 5306481
doi: 10.1093/infdis/jiz049
pmc: PMC6534188
doi:
Substances chimiques
Antibodies, Viral
0
Antigens, Viral
0
Influenza Vaccines
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1904-1912Subventions
Organisme : NCIRD CDC HHS
ID : U01 IP000974
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States
Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Références
Lancet Infect Dis. 2016 Aug;16(8):942-51
pubmed: 27061888
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Clin Infect Dis. 2010 Nov 1;51(9):997-1004
pubmed: 20868284
Vaccine. 2019 Feb 28;37(10):1284-1292
pubmed: 30738647
J Infect Dis. 2016 Oct 1;214(7):1010-9
pubmed: 27190176
Cell. 2018 Apr 5;173(2):417-429.e10
pubmed: 29625056
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578-12583
pubmed: 29109276
Bioinformatics. 2015 Nov 1;31(21):3546-8
pubmed: 26115986
J Vis Exp. 2017 Nov 22;(129):
pubmed: 29286446
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
MMWR Morb Mortal Wkly Rep. 2018 Jun 08;67(22):634-642
pubmed: 29879098
J Infect Dis. 2018 Jul 2;218(3):347-354
pubmed: 29506129
J Virol Methods. 2014 Dec 15;210:7-14
pubmed: 25233882
J Infect Dis. 2019 Sep 13;220(8):1265-1275
pubmed: 30561689
N Engl J Med. 2017 Jun 22;376(25):2427-2436
pubmed: 28636855
Clin Infect Dis. 2016 Oct 15;63(8):1017-25
pubmed: 27369320
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
J Infect Dis. 2015 Oct 15;212(8):1191-9
pubmed: 25858957
Influenza Other Respir Viruses. 2014 May;8(3):384-8
pubmed: 24483237
Nat Med. 2016 Dec;22(12):1465-1469
pubmed: 27820604
Cell Rep. 2015 Jul 7;12(1):1-6
pubmed: 26119736
J Infect Dis. 2013 Mar 15;207(6):974-81
pubmed: 23307936
Lancet. 1973 Mar 24;1(7804):623-5
pubmed: 4121842
Vaccine. 2012 Dec 17;31(1):190-5
pubmed: 23107591
PLoS Pathog. 2017 Oct 23;13(10):e1006682
pubmed: 29059230
PLoS One. 2014 Mar 25;9(3):e92153
pubmed: 24667168
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156